Salem Health values your privacy and wants to be transparent about the data we collect. To offer you the best online experience, we ask that you accept cookies for functionality, performance and advertising. For more information, visit the Terms of Use and Privacy Statement. Do you accept these cookies?
Salem Health Laboratories introduces a new test for the qualitative and quantitative detection of the Hepatitis C virus starting Monday, June 2.
This assay will aid in the diagnosis of active Hepatitis C (HCV) infections and managing HCV- infected patients undergoing HCV antiviral drug therapy. Detection of HCV RNA does not distinguish between acute and chronic states of infection. This assay can be used to measure HCV RNA levels periodically before, during and after treatment to determine sustained virological response (SVR) or non-sustained virological response (NSVR). The results of the Aptima HCV Quant Dx assay must be interpreted within the context of all relevant clinical and laboratory findings.
Note: The assay is not approved for use as a screening test for the presence of HCV RNA in blood or blood products.
This test will replace the current send out test “Hepatitis C Virus (HCV) by Quantitative NAAT,” Test code: XHCVN.
Blood should be collected in Lavender (EDTA), ACD, Plasma Preparation Tube (PPT), Serum Tube or Serum Separator Tube (SST).
Contact the Molecular/Microbiology Department at 503-814-1662. If you are unable to reach someone in the Molecular Department, please call Client Services at 503-814-5227.